-
Mashup Score: 15COVID Data Tracker - 1 year(s) ago
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Bivalent vaccine effectiveness, COVID booster schedule and Evusheld update with Sandra Fryhofer, MD - 1 year(s) ago
AMA Board Chair Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgr…
Source: YouTubeCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0What Happens When COVID-19 Emergency Declarations End? Implications for Coverage, Costs, and Access - 1 year(s) ago
This brief provides an overview of the major health-related COVID-19 federal emergency declarations that have been made since early on in the pandemic, summarizes the flexibilities triggered by eac…
Source: KFFCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
The most-cited reasons for not getting new COVID-19 boosters were lack of awareness about eligibility and overestimations of their own existing immunity.
Source: www.cidrap.umn.eduCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
The most-cited reasons for not getting new COVID-19 boosters were lack of awareness about eligibility and overestimations of their own existing immunity.
Source: www.cidrap.umn.eduCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 16
A study coming out of the Yale School of Public Health finds that annual or bi-annual COVID-19 booster shots will likely have a significant impact in reducing endemic COVID-19 infections.
Source: Yale Daily NewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0The Omicron Booster: Your Questions Answered - 1 year(s) ago
Yale Medicine infectious diseases doctors discuss the new Omicron-specific COVID-19 booster.
Source: Yale MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0CDC, FDA Announce Safety Signal Related to the Pfizer-BioNTech Bivalent COVID-19 Vaccine - 1 year(s) ago
The two agencies said one of the vaccine surveillance systems prompted an investigation into whether there was a safety concern for ischemic stroke in seniors for this booster.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0What We’re Reading: Expanding Naloxone Access; US Childhood Vaccinations Drop; New COVID-19 Booster Reconsidered - 1 year(s) ago
Greater availability of naloxone spray, including over the counter, may reduce opioid overdoses; vaccination rates drop once again for US children; some experts question the necessity of the updated COVID-19 booster shot.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2Immune Imprinting and the Prevention of Spread - 1 year(s) ago
Kevin Kavanagh, MD, discusses the continued concerns about COVID-19 efficacy reduction and what he believes should be done to protect against the further spread.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
People 5 & up who are #vaxxed & #boosted w/ updated bivalent #COVID19 #booster shot are 12.7 times less likely to die than unvaccinated & 2.4 times less likely to die than those vaxxed w/o updated booster. In 🇺🇸, 84% haven’t had booster. 🥴 #MedTwitter https://t.co/smyItKtGUd https://t.co/H9y1eTOqAK